Botswana warns of pregancy-threatening side-effects of ARV drug Dolutegravir
by Guest Author from Outbreak News Today on (#3RSVD)
By Oscar Nkala The Botswana Ministry of Health and Wellness has warned the public of 'potential safety issues' arising from the use of anti-retroviral drug Dolutegravir (DTG) among pregnant women. In a statement, the government said a new study suggests the drug can affect neural tube development during the early stages of conception. Neural tube ["]
The post Botswana warns of pregancy-threatening side-effects of ARV drug Dolutegravir appeared first on Outbreak News Today.